Exogenous Ketones in Cardiovascular Disease and Diabetes: From Bench to Bedside
Urna Kansakar, Crystal Nieves Garcia, Gaetano Santulli, Jessica Gambardella, Pasquale Mone, Stanislovas S. Jankauskas, Angela Lombardi · 2024
Read Exogenous Ketones in Cardiovascular Disease and Diabetes: From Bench to Bedside by Urna Kansakar, Crystal Nieves Garcia, Gaetano Santulli, Jessica Gambardella, Pasquale Mone, Stanislovas S. Jankauskas, Angela Lombardi (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11642481.txt.
Description
Urna Kansakar and six colleagues review exogenous ketones, supplements that raise ketone levels in the blood, for heart disease and diabetes. Ketones are made in the liver from fatty acids and carry energy when glucose runs low. Diets that raise them have drawn wide interest.
The review weighs lab and clinical evidence on heart muscle cells and on insulin-making beta cells in the pancreas. Modest ketone levels seem to help both, though too much can trigger dangerous ketoacidosis in diabetes. The authors also discuss SGLT2 inhibitor drugs, which raise the main ketone, beta-hydroxybutyrate. They frame ketones as a possible route to heart-protective therapy.
Catalog record
| CREATOR | Urna Kansakar, Crystal Nieves Garcia, Gaetano Santulli, Jessica Gambardella, Pasquale Mone, Stanislovas S. Jankauskas, Angela Lombardi |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 54 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |